Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mineralys Therapeutics Inc (MLYS)

Mineralys Therapeutics Inc (MLYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mineralys Therapeutics Inc 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 USA

www.mineralystx.com Employees: 28 P: 888-378-6240

Description:

Mineralys Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Mineralys Therapeutics Inc. is based in RADNOR, Pa.

Key Statistics

Overview:

Market Capitalization, $K 685,238
Enterprise Value, $K 635,938
Shares Outstanding, K 49,727
Annual Sales, $ 0 K
Annual Net Income, $ -71,900 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -41,010 K
EBIT, $ -134,510 K
EBITDA, $ -134,510 K
60-Month Beta 1.93
% of Insider Shareholders 33.24%
% of Institutional Shareholders 84.46%
Float, K 33,198
% Float 66.76%
Short Volume Ratio 0.44

Growth:

1-Year Return 65.80%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.83 on 08/13/24
Next Earnings Date 11/05/24 [--]
Earnings Per Share ttm -2.71
EPS Growth vs. Prev Qtr -18.57%
EPS Growth vs. Prev Year -167.74%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MLYS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -42.61%
Return-on-Assets % -40.06%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.39
Book Value/Share 5.84
Interest Coverage -4.03
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar